A citation-based method for searching scientific literature

Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P Geurink, Alexander Wilhelm, Gerbrand J van der Heden van Noort, Huib Ovaa, Stefan Müller, Klaus-Peter Knobeloch, Krishnaraj Rajalingam, Brenda A Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Dikic. Nature 2020
Times Cited: 408



Yahira M Báez-Santos, Scott J Barraza, Michael W Wilson, Michael P Agius, Anna M Mielech, Nicole M Davis, Susan C Baker, Scott D Larsen, Andrew D Mesecar. J Med Chem 2014
Times Cited: 114




List of shared articles



Times cited

Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
Chia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, Kai S Yang, Ge Yu, Yuchen Qiao, Shiqing Xu, Wenshe Ray Liu. ChemMedChem 2022
12

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.
Shenghua Gao, Tianguang Huang, Letian Song, Shujing Xu, Yusen Cheng, Srinivasulu Cherukupalli, Dongwei Kang, Tong Zhao, Lin Sun, Jian Zhang,[...]. Acta Pharm Sin B 2022
7


Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity.
Zhengnan Shen, Kiira Ratia, Laura Cooper, Deyu Kong, Hyun Lee, Youngjin Kwon, Yangfeng Li, Saad Alqarni, Fei Huang, Oleksii Dubrovskyi,[...]. J Med Chem 2022
24

Deubiquitinases: From mechanisms to their inhibition by small molecules.
Sven M Lange, Lee A Armstrong, Yogesh Kulathu. Mol Cell 2022
10

Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2.
Lucianna H Santos, Thales Kronenberger, Renata G Almeida, Elany B Silva, Rafael E O Rocha, Joyce C Oliveira, Luiza V Barreto, Danielle Skinner, Pavla Fajtová, Miriam A Giardini,[...]. bioRxiv 2022
0

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development.
Zongyang Lv, Kristin E Cano, Lijia Jia, Marcin Drag, Tony T Huang, Shaun K Olsen. Front Chem 2022
4

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses.
Brendan T Freitas, Daniil A Ahiadorme, Rahul S Bagul, Ian A Durie, Samir Ghosh, Jarvis Hill, Naomi E Kramer, Jackelyn Murray, Brady M O'Boyle, Emmanuel Onobun,[...]. ACS Infect Dis 2022
0

Targeting papain-like protease for broad-spectrum coronavirus inhibition.
Shuofeng Yuan, Xiaopan Gao, Kaiming Tang, Jian-Piao Cai, Menglong Hu, Peng Luo, Lei Wen, Zi-Wei Ye, Cuiting Luo, Jessica Oi-Ling Tsang,[...]. Protein Cell 2022
1

Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor.
Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang. ACS Infect Dis 2022
1

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors.
Dale J Calleja, Nathan Kuchel, Bernadine G C Lu, Richard W Birkinshaw, Theresa Klemm, Marcel Doerflinger, James P Cooney, Liana Mackiewicz, Amanda E Au, Yu Q Yap,[...]. Front Chem 2022
0

Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA.
Reena Kumari, Viney Kumar, Poonam Dhankhar, Vikram Dalal. J Biomol Struct Dyn 2022
0